[1]
Campos, F.F. de et al. 2019. LIRAGLUTIDE AS A NOVEL DNA DEMETHYLATING AGENT AND ITS POTENTIAL USE IN THE ADJUVANT TREATMENT OF HIGLY INVASIVE BREAST CANCER. Mastology. 29, 3 (Sep. 2019), 14.